An interventional study of Back Exosuit in Low Back Pain, sponsored by Boston University Charles River Campus. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 712 studies in Low Back Pain with a site in United States — 100 open to participants now, 126 under way, 3 of them phase 3. Low Back Pain · United States.
Among the 712 studies in Low Back Pain with a site in United States, this one is the 415th largest by enrollment of the 623 interventional ones that give a count, is one of 32 that started in 2024, is one of 408 with no phase, and was the 578th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →100 of the 712 studies in Low Back Pain with a site in United States are open now. Recruiting first, the newest first:
Weill Medical College of Cornell University · Sites in United States
Ages 18+
New York Medical College · Sites in United States
Ages 18+
Loma Linda University · Sites in United States
Ages 18–65 · Healthy volunteers
University of Central Florida · Sites in United States
Ages 18–65
Eli Lilly and Company · Sites in United States, Puerto Rico
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
712 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 35 · Phase 2 80 · Phase 3 73 · Phase 4 50
First in 1977; this study’s year is marked. 32 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 44 is below the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Median enrollment 79 across the 623 interventional studies, 90 across the 85 observational. Of the 513 that completed or were terminated, 207 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
156 of 712 have an industry lead sponsor. The 10 most frequent:
Boston University Charles River Campus is the lead sponsor of 160 studies on the registry; 34 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 11 (79%) have results posted.
Boston University Charles River Campus has 1 study filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
52 of the studies in Low Back Pain with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07254806Phase 3DiscGenics, Inc.A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease | 2027-11-24 |
| NCT07125027National University of Natural MedicineA Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE | 2026-11 |
| NCT07652944Joe X. ZhangTrial to Test the Efficacy of Using Magnetic Fields to Stimulate the Back to Treat Chronic Lower Back Pain. | 2026-11 |
| NCT04730700University of Kansas Medical CenterEvaluation of Multi-Tined Expandable Electrode (MEE) Efficacy and Safety in Treatment of Lumbar Facet Arthropathy by Radiofrequency Neurotomies Compared to Conservative Medical Management. | 2026-11-30 |
| NCT06007976Mayo ClinicLLLT to Reduce Low Back Pain | 2026-12 |
Add all 52 to your calendar (.ics) → With an account.
Among the 712 studies in Low Back Pain with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a NIAMS-sponsored clinical trial being conducted through the NIH Helping to End Addition Long-term (HEAL) Initiative's Back Pain Consortium (BACPAC) Research Program. This is a single-arm controlled trial with individuals aged 18-70 with low back pain (LBP). This study investigates the effect(s) of augmenting physical therapy (PT) interventions with the use of an experimental wearable soft robotic device ('exosuit').
Low back pain (LBP) has a lifetime prevalence of 80%, with approximately 20% of individuals experiencing recurrent episodes or chronic LBP (cLBP). Unfortunately, the evidence for the effectiveness of most rehabilitative treatment is low. With an economic burden approaching $100-billion in the United States alone, the National Institutes of Health has invested millions of dollars in innovative technologies aiming to improve rehabilitative care for low back injuries. As part of this initiative, the investigator's collaborative network of expert clinicians, engineers, and researchers have developed and tested robotic apparel technology (exosuit) that supplements ergonomic and biomechanical training and can be utilized by clinicians in the treatment of individuals with LBP.
Failed rehabilitation, and thus progression from acute to cLBP, is thought to be caused by maladaptive motor control strategies, muscle hyperactivity, reduced movement variability, and development of fear-avoidance-beliefs. The exosuit technology was designed to reduce exertion, encourage safe, varied movement strategies, and promote recovery through well-timed assistive forces to the trunk and hips during flexion postures and lifting tasks. The proposed project builds on this work through use of the exosuit to augment traditional physical therapy care. In doing so, the investigators will determine whether this technology can enhance rehabilitation after back injuries, interrupt the progression of acute to chronic LBP, encourage non-maladaptive movement strategies, and expedite the timeline of return to prior level of function.
To examine the effects of exosuit augmented physical therapy rehabilitation and reduce disability, the investigators will recruit individuals with LBP who are referred to or receiving physical therapy into a single arm clinical trial. The investigators will evaluate feasibility, safety and usability of the exosuit, as well as changes in pain and disability throughout 6 weeks of rehabilitation and compare outcomes to a historical control group who received usual care. The investigators will also evaluate changes in fear-avoidance beliefs, range of motion, and motor control and compare outcomes between exosuit-augmented and no suit conditions over the 6 weeks. Primary outcomes of feasibility, usability, and safety of using a back exosuit to augment routine physical therapy will be evaluated. Secondary outcomes include the efficacy of using a back exosuit to augment routine physical therapy, measured by comparing changes in self-perceived pain and disability compared to the historical control group. Tertiary outcomes include the identification of interventional phenotypes by determining the relationship between changes in symptoms and changes in biomechanics function through exosuit-augmented physical therapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will attend an in person screening, initial visit (1), 10 (2-11) sessions of physical therapy and a discharge visit (12). Participants will undergo a comprehensive biomechanical analysis on visits 1, 3, 6, 9 and 12, completing an extensive battery of surveys at visits 1, discharge, and 1-month post-discharge. Treatment will incorporate evidence-based physical therapy care based on clinical presentation to include manual therapy, therapeutic exercise, and functional therapeutic activities. A portion of each session will include exosuit use.
Device: Back Exosuit
The device is worn like a backpack. It weighs 6 pounds. Participants will be able to perform movements naturally in the device. A ribbon serves as an external muscle to reduce the load and effort during lifting. As participants bend forward, the device assists the participant by supporting some of their body weight by gently pulling back. As participants stand up, the device assists them by gently pulling their trunk upright. Participants will feel the level of assistance change slightly as they move faster or slower. Participants will use this device during 20-40 minutes of physical therapy exercises during 12 visits over 4-6 weeks. Once it is fit and adjusted to each participant's comfort, the physical therapist will control the level of assistance the device provides similarly to how they would adapt any given exercise. Participants may start with more assistance and wean down over the course of the study.
Suit Usability Measured by Quebec User Evaluation of Satisfaction With Assistive Technology (QUEST Survey 2.0)
Suit usability measured by the QUEST survey 2.0. The QUEST is a standardized usability scale to determine a user's device satisfaction. Results range from 1 to 5 on a Likert Scale, with higher scores (5) corresponding to a very satisfied response.
Time frame: Measured periodically (at visits 1, 3, 6, 9, 12) between baseline (time 0) and 6-8 weeks of treatment.
Suit Safety Measured by Patient-reported Pain
The Numerical Rating Scale of Pain will measure patient-reported levels of current pain intensity at the beginning and end of every study visit. Results range from 0 to 10, with higher scores indicating increased pain intensity.
Time frame: Pre and Post Every Visit including baseline (time 0), all follow-up visits (up to 8 weeks of treatment)
Suit Effect & Safety Measured by Perceived Task Discomfort
The patient-reported level of task discomfort will be measured at the end of selected biomechanical assessment tasks (performed with the suit in a slack and active condition). Participants will rank task discomfort on a numerical rating scale of task discomfort. Results range from 0 to 10, with higher scores indicating higher total body difficulty.
Time frame: Measured periodically (at visits 1, 3, 6, 9, 12) between baseline (time 0) and 6-8 weeks of treatment.
Suit Effect Measured by Concern of Movement
Patient-reported level of concern of movement will be measured at the end of each biomechanical visit. Four selected images from the Photo Series of Daily Activity will be ranked, with the participants envisioning themselves completing the task with or without the aid of the exosuit (Quirk et al., 2023). Results range from 0 to 10, with higher scores indicating higher concern with completing the task.
Time frame: Measured periodically (at visits 1, 3, 6, 9, 12) between baseline (time 0) and 6-8 weeks of treatment.
Suit Effect Measured by Perceived Task Effort
Patient-reported level of task effort will be measured at the end of selected biomechanical assessment tasks (performed with the suit in a slack and active condition). Participants will rank task difficulty on a numerical rating scale of task difficulty. Results range from 0 to 10, with higher scores indicating higher task difficulty.
Time frame: Measured periodically (at visits 1, 3, 6, 9, 12) between baseline (time 0) and 6-8 weeks of treatment.
Functional Suit Effect Measured by Peak Deadlift Pull Force
Measured during maximum voluntary isometric contractions pounds will be measured using a stationary dynamometer. Peak full force will be measured for the slack and active suit condition.
Time frame: Measured periodically (at visits 1, 3, 6, 9, 12) between baseline (time 0) and 6-8 weeks of treatment.
Failure Percentage Level 6
For this progressive lifting test starting in a randomized active or slack condition women and men would start from level 1 lifting a 8 or 13 pound weighted tote off of the floor and unto a 75cm high table with the goal to complete 4 repetitions within 20 seconds. If the participants were successful (pass) they would advance to the next level adding 5 pounds to the tote, however if they were unwilling or failed a level the task would end. The task advanced to a maximum of 6 levels corresponding to a 33 and 38 pound mass for women and men respectively. The following outcome identifies the % of participants who failed the task at or before level 6 in their slack and active condition.
Time frame: Measured periodically (at visits 1, 3, 6, 9, 12) between baseline (time 0) and 6-8 weeks of treatment.
Functional Suit Effect Measured by Endurance Lifting Task
Measured during dynamic 2.5 minute dynamic asymmetric lifting task. The maximum number of continuous repetitions (rep) performed will compared between the slack and active suit conditions.
Time frame: Measured periodically (at visits 1, 3, 6, 9, 12) between baseline (time 0) and 6-8 weeks of treatment.
Pain Measured by Numerical Rating Scale of Pain (Worst in Last 24 Hours)
Patient-reported level of their worse pain intensity in the last 24 hours will be measured by the Numerical Rating Scale of Pain, at the beginning of every study visit. Results range from 0 to 10, with higher scores indicating increased pain intensity.
Time frame: Pre Every Visit including baseline (time 0), all follow-up visits
Patient-reported Disability Score Measured by the Modified Oswestry Disability Questionnaire (MDQ)
Patient-reported pain intensity and interference is measured by the Modified Oswestry Disability Questionnaire (MDQ) scale. The MDQ is a series of 10 questions. Results range from 0 to 50, with higher scores indicating increased low-back related disability.
Time frame: Pre Every Visit including baseline (time 0)
| Milestone | Exosuit Augmented Physical Therapy |
|---|---|
| Started | 44 |
| Completed | 39 |
| Not completed | 5 |
| Withdrew: Lost to follow-up | 1 |
| Withdrew: Withdrawal by subject | 2 |
| Withdrew: Lack of time | 1 |
| Withdrew: Moved | 1 |
Suit usability measured by the QUEST survey 2.0. The QUEST is a standardized usability scale to determine a user's device satisfaction. Results range from 1 to 5 on a Likert Scale, with higher scores (5) corresponding to a very satisfied response.
| units on a scale | Exosuit Augmented Physical Therapy |
|---|---|
| Visit 1 | 4.2 ± 0.7 |
| Visit 3 | 4.3 ± 0.6 |
| Visit 6 | 4.4 ± 0.7 |
| Visit 9 | 4.4 ± 0.6 |
| Visit 12 | 4.4 ± 0.6 |
The Numerical Rating Scale of Pain will measure patient-reported levels of current pain intensity at the beginning and end of every study visit. Results range from 0 to 10, with higher scores indicating increased pain intensity.
| units on a scale | Start of Visit for Exosuit Augmented Physical Therapy | End of Visit for Exosuit Augmented Physical Therapy |
|---|---|---|
| Visit 1 | 2.4 ± 1.5 | 3.7 ± 2.2 |
| Visit 3 | 2.2 ± 1.6 | 3.0 ± 1.5 |
| Visit 6 | 2.1 ± 1.8 | 3.4 ± 1.9 |
| Visit 9 | 1.5 ± 1.1 | 2.4 ± 1.7 |
| Visit 12 | 1.5 ± 1.4 | 2.6 ± 2.2 |
The patient-reported level of task discomfort will be measured at the end of selected biomechanical assessment tasks (performed with the suit in a slack and active condition). Participants will rank task discomfort on a numerical rating scale of task discomfort. Results range from 0 to 10, with higher scores indicating higher total body difficulty.
| units on a scale | Exosuit Augmented Physical Therapy- Active | Exosuit Augmented Physical Therapy- Slack |
|---|---|---|
| Visit 1 | 4.6 ± 2.3 | 5.2 ± 2.4 |
| Visit 3 | 3.9 ± 1.7 | 4.2 ± 1.8 |
| Visit 6 | 4.0 ± 1.8 | 4.2 ± 1.8 |
| Visit 9 | 3.5 ± 1.8 | 3.9 ± 1.7 |
| Visit 12 | 3.7 ± 2.2 | 3.8 ± 2.2 |
Patient-reported level of concern of movement will be measured at the end of each biomechanical visit. Four selected images from the Photo Series of Daily Activity will be ranked, with the participants envisioning themselves completing the task with or without the aid of the exosuit (Quirk et al., 2023). Results range from 0 to 10, with higher scores indicating higher concern with completing the task.
| units on a scale | Exosuit Augmented Physical Therapy for Shovel Active | Exosuit Augmented Physical Therapy for Shovel Stack |
|---|---|---|
| Visit 1 | 3.5 ± 2.1 | 5.2 ± 2.5 |
| Visit 3 | 3.1 ± 2.4 | 4.7 ± 2.6 |
| Visit 6 | 2.9 ± 2.3 | 4.3 ± 2.3 |
| Visit 9 | 2.7 ± 2.4 | 4.4 ± 2.7 |
| Visit 12 | 2.6 ± 2.1 | 4.1 ± 2.1 |
Patient-reported level of task effort will be measured at the end of selected biomechanical assessment tasks (performed with the suit in a slack and active condition). Participants will rank task difficulty on a numerical rating scale of task difficulty. Results range from 0 to 10, with higher scores indicating higher task difficulty.
| units on a scale | Exosuit Augmented Physical Therapy Active Effort | Exosuit Augmented Physical Therapy Slack Effort |
|---|---|---|
| Visit 1 | 6.2 ± 1.9 | 6.8 ± 1.6 |
| Visit 3 | 5.6 ± 2.0 | 6.1 ± 2.1 |
| Visit 6 | 5.3 ± 1.7 | 6.1 ± 2.0 |
| Visit 9 | 5.4 ± 2.3 | 6.0 ± 2.0 |
| Visit 12 | 5.4 ± 2.3 | 5.6 ± 2.1 |
Measured during maximum voluntary isometric contractions pounds will be measured using a stationary dynamometer. Peak full force will be measured for the slack and active suit condition.
| pounds | Exosuit Augmented Physical Therapy Pull Force Active | Exosuit Augmented Physical Therapy Pull Force Slack |
|---|---|---|
| Visit 1 | 191.9 ± 74.2 | 184.3 ± 73.5 |
| Visit 3 | 198.3 ± 81.4 | 193.7 ± 93.2 |
| Visit 6 | 204.0 ± 85.6 | 201.5 ± 87.2 |
| Visit 9 | 216.7 ± 94.6 | 215.0 ± 96. |
| Visit 12 | 206.8 ± 90.6 | 200.3 ± 91.5 |
For this progressive lifting test starting in a randomized active or slack condition women and men would start from level 1 lifting a 8 or 13 pound weighted tote off of the floor and unto a 75cm high table with the goal to complete 4 repetitions within 20 seconds. If the participants were successful (pass) they would advance to the next level adding 5 pounds to the tote, however if they were unwilling or failed a level the task would end. The task advanced to a maximum of 6 levels corresponding to a 33 and 38 pound mass for women and men respectively. The following outcome identifies the % of participants who failed the task at or before level 6 in their slack and active condition.
| Participants | Exosuit Augmented Physical Therapy Active | Exosuit Augmented Physical Therapy Active Slack |
|---|---|---|
| Visit 1 | 6 | 9 |
| Visit 3 | 7 | 8 |
| Visit 6 | 5 | 6 |
| Visit 9 | 3 | 3 |
| Visit 12 | 2 | 3 |
Measured during dynamic 2.5 minute dynamic asymmetric lifting task. The maximum number of continuous repetitions (rep) performed will compared between the slack and active suit conditions.
| number of repetitions | Exosuit Augmented Physical Therapy Continuous Reps Active | Exosuit Augmented Physical Therapy Continuous Reps Slack |
|---|---|---|
| Visit 1 | 33.7 ± 18.3 | 28.1 ± 20.4 |
| Visit 3 | 34.7 ± 23.5 | 32.0 ± 21.2 |
| Visit 6 | 34.7 ± 18.9 | 29.9 ± 20.5 |
| Visit 9 | 40.5 ± 25.3 | 34.8 ± 26.1 |
| Visit 12 | 43.4 ± 26.4 | 36.7 ± 22.4 |
Patient-reported level of their worse pain intensity in the last 24 hours will be measured by the Numerical Rating Scale of Pain, at the beginning of every study visit. Results range from 0 to 10, with higher scores indicating increased pain intensity.
| score on a scale | Exosuit Augmented Physical Therapy |
|---|---|
| Visit 1 | 2.7 ± 1.6 |
| Visit 2 | 2.5 ± 1.7 |
| Visit 3 | 2.4 ± 1.6 |
| Visit 4 | 2.4 ± 1.8 |
| Visit 5 | 1.8 ± 1.7 |
| Visit 6 | 2.2 ± 1.7 |
| Visit 7 | 1.9 ± 1.7 |
| Visit 8 | 1.6 ± 1.3 |
| Visit 9 | 1.6 ± 1.2 |
| Visit 10 | 1.2 ± 1.0 |
| Visit 11 | 1.5 ± 1.1 |
| Visit 12 | 0.8 ± 1.0 |
Patient-reported pain intensity and interference is measured by the Modified Oswestry Disability Questionnaire (MDQ) scale. The MDQ is a series of 10 questions. Results range from 0 to 50, with higher scores indicating increased low-back related disability.
| score on a scale | Exosuit Augmented Physical Therapy |
|---|---|
| Visit 1 | 15.8 ± 11.7 |
| Visit 2 | 14.8 ± 10.3 |
| Visit 3 | 13.0 ± 9.5 |
| Visit 4 | 13.2 ± 9.9 |
| Visit 5 | 10.9 ± 9.3 |
| Visit 6 | 11.8 ± 9.8 |
| Visit 7 | 10.9 ± 9.0 |
| Visit 8 | 9.4 ± 9.0 |
| Visit 9 | 8.9 ± 9.4 |
| Visit 10 | 8.6 ± 9.0 |
| Visit 11 | 7.1 ± 7.4 |
| Visit 12 | 7.1 ± 5.2 |
Collected over 6-8 weeks. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Exosuit Augmented Physical Therapy | 0/44 (0%) | 0/44 (0%) | 4/44 (9.1%) |
| Event | Exosuit Augmented Physical Therapy |
|---|---|
| Increased lower back painMusculoskeletal and connective tissue disorders | 4/44 |
| Age, Continuous(years) | Exosuit Augmented Physical Therapy |
|---|---|
| Mean | 31.7 ± 11.1 |
| Sex: Female, Male(Participants) | Exosuit Augmented Physical Therapy |
|---|---|
| Female | 20 |
| Male | 24 |
| Ethnicity (NIH/OMB)(Participants) | Exosuit Augmented Physical Therapy |
|---|---|
| Hispanic or Latino | 6 |
| Not Hispanic or Latino | 38 |
| Unknown or Not Reported | 0 |
| Race (NIH/OMB)(Participants) | Exosuit Augmented Physical Therapy |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 10 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 4 |
| White | 27 |
| More than one race | 3 |
| Unknown or Not Reported | 0 |
| Region of Enrollment(participants) | Exosuit Augmented Physical Therapy |
|---|---|
| United States | 44 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — De-identified IPD will be made available to other researchers in BACPAC.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: The data will be made available upon publication of the study. It will remain available thereafter on https://healdata.org.
Access criteria: Members of BACPAC can access study data in the HEAL Initiative Data Repository using permalink: https://healdata.org/portal/discovery/HDP00349/
Data sharing details ↗ · healdata.org
Ran from Mar 2024 to primary completion in May 2025, 13 months.
Results were first posted in Sep 2026, 1 year 4 months after primary completion.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's 13 months is above that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Boston University Charles River Campus →